Animal models in the genomic era: possibilities and limitations with special emphasis on schizophrenia

被引:22
作者
Ellenbroek, BA [1 ]
机构
[1] Dept Psychoneuropharmacol, NL-6500 HB Nijmegen, Netherlands
来源
BEHAVIOURAL PHARMACOLOGY | 2003年 / 14卷 / 5-6期
关键词
animal models; schizophrenia; genetic model; environmental models; gene-environment interaction;
D O I
10.1097/01.fbp.0000087736.21047.3c
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Although the advances in molecular genetics have revolutionized many areas of the life sciences, they have, so far, been of limited use in the development of animal models for brain diseases. This is due to the fact that the genetics of most neurological and psychiatric diseases are highly complex, presumably involving multiple genes, most of which are still unknown. Moreover, in many brain diseases, non-genetic factors also play an important role. This leads to a general model in which several genetic factors interact with a number of early and late environmental factors, ultimately culminating in the disease. We have tried to illustrate how the existing genetic and environmental models for schizophrenia fit into this general etiological scheme, and how these models can be further improved by focusing specifically on the interaction between genetic and environmental factors. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 111 条
[1]  
ADLER LE, 1982, BIOL PSYCHIAT, V17, P639
[2]   NEUROPHYSIOLOGICAL STUDIES OF SENSORY GATING IN RATS - EFFECTS OF AMPHETAMINE, PHENCYCLIDINE, AND HALOPERIDOL [J].
ADLER, LE ;
ROSE, G ;
FREEDMAN, R .
BIOLOGICAL PSYCHIATRY, 1986, 21 (8-9) :787-798
[3]   Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia [J].
Agid, O ;
Shapira, B ;
Zislin, J ;
Ritsner, M ;
Ritsner, M ;
Hanin, B ;
Murad, H ;
Troudart, T ;
Bloch, M ;
Heresco-Levy, U ;
Lerer, B .
MOLECULAR PSYCHIATRY, 1999, 4 (02) :163-172
[4]  
[Anonymous], 1982, SCHIZOPHRENIA EPIGEN
[5]  
ARSENEAULT L, 2003, BRIT MED J, V325, P1212
[6]  
Ballard TM, 2002, J NEUROSCI, V22, P6713
[7]   DECREASED EXPRESSION OF THE EMBRYONIC FORM OF THE NEURAL CELL-ADHESION MOLECULE IN SCHIZOPHRENIC BRAINS [J].
BARBEAU, D ;
LIANG, JJ ;
ROBITAILLE, Y ;
QUIRION, R ;
SRIVASTAVA, LK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2785-2789
[8]   DIFFERENTIAL PERFORMANCE OF ACUTE AND CHRONIC-SCHIZOPHRENICS IN A LATENT INHIBITION TASK [J].
BARUCH, I ;
HEMSLEY, DR ;
GRAY, JA .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1988, 176 (10) :598-606
[9]  
BASSETT AS, 2001, NEUROSCI NEWS, V4, P20
[10]   NEUROCHEMISTRY AND TOXIN MODELS IN HUNTINGTONS-DISEASE [J].
BEAL, MF .
CURRENT OPINION IN NEUROLOGY, 1994, 7 (06) :542-547